Analysen von Jessica Fye
10.03.25 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
27.01.25 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
18.12.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
11.12.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
15.11.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
15.11.24 | Halozyme Therapeutics Neutral | JP Morgan Chase & Co. | |
05.11.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
16.09.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
Werbung
|
|||
13.09.24 | Moderna Underweight | JP Morgan Chase & Co. | |
09.09.24 | BioNTech (ADRs) Underweight | JP Morgan Chase & Co. | |
16.08.24 | BioNTech (ADRs) Underweight | JP Morgan Chase & Co. | |
30.10.23 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
11.01.23 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
21.11.22 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
24.10.22 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. |